On this page

Start with the purpose of treatment

Treatment discussions concern blood supply, future events and existing symptoms or injury. Medical care and revascularization are not interchangeable interventions. The Japanese guideline discusses antiplatelet treatment for ischemic disease with low-level evidence and separate care for hemorrhagic presentations.1

Ask what the proposed treatment is intended to change and how benefit and harm will be measured. A person with recurrent ischemic episodes is asking a different question from an adult recovering from hemorrhage or someone with an incidental vascular finding. Treatment is not selected from the disease name alone.

Direct, indirect and combined procedures

Direct revascularization connects a donor artery to an artery supplying the brain; STA–MCA bypass is one example. Indirect revascularization places vascularized tissue in contact with the brain so additional vessels can develop. Combined revascularization uses both approaches. These are blood-supply operations, not removal of an AVM or microvascular decompression of a nerve.1

Direct flow augmentation and the development of indirect collaterals have different timing. Indirect circulation takes time to develop, and a successful operation does not mean its full effect is immediate. ESO's comparison discusses this distinction and the limits of technique evidence.2

EDAS is an indirect technique whose name refers to the tissues used in that approach. Different indirect procedures and combinations are not identical. Ask the surgeon to explain the proposed operation in ordinary language, including its intended territory and why it fits the anatomy.

Who is being considered?

ESO supports specialist consideration of revascularization for ischemic presentations when symptoms or hemodynamic impairment are relevant, while distinguishing adult and pediatric circumstances. Several practical statements are consensus-based. For asymptomatic adults, risk and benefit remain uncertain; an incidental diagnosis is not an automatic instruction to operate.2

JAM tested bilateral direct bypass against conservative care in Japanese adults after intracranial hemorrhage. Its findings concern recurrent bleeding in that selected population. It is not a randomized comparison of all three techniques or a pediatric trial.3

Questions before an operation

Ask which patient group best matches your situation, what alternatives were discussed, and what uncertainty remains. Clarify how timing after a recent event is chosen, which early complications the team monitors and how follow-up will be arranged. An operation may involve a different plan for each side; ask how that decision is made rather than assuming symmetry.

Discuss prescribed medicines, anesthesia and the care plan around the operation with the treating team, including blood pressure, fluids and antiplatelet medicines.

References

  1. Fujimura M et al. Neurologia medico-chirurgica. 2022;62:165–170. doi:10.2176/jns-nmc.2021-0382. Source ↩
  2. Bersano A et al. European Stroke Journal. 2023;8:55–84. doi:10.1177/23969873221144089. Corrected March 2023. Source ↩
  3. Miyamoto S et al. Stroke. 2014;45:1415–1421. doi:10.1161/STROKEAHA.113.004386. PubMed ↩